Cytarabine

Thông số

147-94-4Số CAS

205-705-9Số EC

4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-oneTên IUPAC

C9H13N3O5Công thức hóa học

243.22 g/molKhối lượng phân tử

cytarabine; 147-94-4; Ara-C; Cytosine arabinoside; Aracytidine; Cytarabinoside; Arabinocytidine; Spongocytidine; Aracytin; Alexan; Depocyt; Udicil; Cytosar-U; Aracytine; Arabitin; Erpalfa; Cytarabina; Arafcyt; Cytosine beta-D-arabinofuranoside; 1-beta-D-Arabinofuranosylcytosine; DepoCyte; arabinocytosine; Citarabina; Cytarabinum; Cytosar; Arabinofuranosylcytosine; Cytosine-beta-D-arabinofuranoside; Cytosinearabinoside; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone; Arabinosylcytosine; beta-D-Arabinosylcytosine; Cytarabin; Cytosine arabinofuranoside; Cytosine beta-D-arabinoside; Arabinoside C; 1beta-D-Arabinosylcytosine; Cytosine-1-beta-D-arabinofuranoside; Cytosine arabinose; cytarabine liposome; 1beta-Arabinofuranasylcytosine; Beta-cytosine arabinoside; Cytosine 1-beta-D-arabinofuranoside; 1beta-D-Arabinofuranosylcytosine; 1-beta-D-Arabinofaranosylcytosine; beta-Arabinosylcytosine; Ara-Cytidine; U 19920A; Cytosine-beta-arabinoside; 4-amino-1-beta-D-arabinofuranosylpyrimidin-2(1H)-one; U-19,920; 1-Arabinofuranosylcytosine; DTXSID3022877; Cytosine, 1-beta-D-arabinosyl-; 1-beta-D-Arabinosylcytosine; 1-beta-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone; Cytosine, 1-beta-D-arabinofuranosyl-; 1-beta-arabinofuranosylcytosine; U-19920; CHEBI:28680; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin; 04079A1RDZ; Arabinofuranosyl Cytidine; NSC-287459; 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one; 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; 2(1H)-Pyrimidinone, 4-amino-1-beta-D-arabinofuranosyl-; DTXCID702877; NCI-C04728; VYXEOS COMPONENT CYTARABINE; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine; AC-1075; NSC287459; Cytarbel; Cytosar U; Tarabine PFS; Ara C; Ara-cell; Arabine; CHX-3311; NSC 63878; 4-amino-1-((2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)pyrimidin-2-one; beta Ara C; 1-(beta-d-arabinofuranosyl)cytosine; 4-amino-1-((2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-1,2-dihydropyrimidin-2-one; cytarabine ocphosphate; Arabinoside, Cytosine; Alexan 100; RefChem:5727; U 19920; 2(1H)-Pyrimidinone, 4-amino-1beta-D-arabinofuranosyl-; L01BC01; WR-28453; 205-705-9; 4-amino-1-(3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)pyrimidin-2-one; Starasid; Tarabine; 4-Amino-1-((2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one; Cytarabinum [INN-Latin]; Citarabina [INN-Spanish]; AraC; MFCD00066487; Cytosine |A-D-Arabinofuranoside; Depocyt (liposomal); C9H13N3O5; CHEMBL803; 2(1H)-Pyrimidinone, 4-amino-1-.beta.-D-arabinofuranosyl-; AR3; CHX 3311; 1-beta-D-arabinofuranosyl-cytosine; CCRIS 913; HSDB 3049; NCGC00093356-03; 2(1H)-Pyrimidinone, 4-amino-1-y-D-arabinofuranosyl- [CAS]; Cytonal; NSC 287459; beta-Ara C; AI3-52329; Cytosine arabinoside (VAN); (beta-D-Arabinofuranosyl)cytosine; Cytarabine Impurity; cytarabine liposome injection; Arabinosyl Cytosine; Cytosine, beta-D-arabinoside; 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one; CAS-147-94-4; SMR000449317; Depocyt (TN); EINECS 205-705-9; 1-(arabinofuranosyl)cytosine; Cytartbine; UNII-04079A1RDZ; 1-.beta.-D-Arabinofuranosylcytosine; Cytarabine; 4-amino-1-beta-d-arabinofuranosylpyrimidin-2(1H)-one; SR-01000075773; Cytarabine RS; Cytarabine CRS; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon [Czech]; 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin [Czech]; 1-.beta.-D-arabinofuranosyl-cytosine; 4-Amino-1-b-D-arabinofuranosyl-2-(1H)-pyrimidinone; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon; 1-beta-D-Arabinofuranosylcytosine, Cytosine Arabinoside; Cytarabine [USAN:USP:INN:BAN:JAN]; MK 8242; Cytarabine (Standard); beta -arabinosylcytosine; Arabinofuranosylcytosine?; CYTARABINE [MI]; CYTARABINE [INN]; CYTARABINE [JAN]; CYTARABINE [HSDB]; CYTARABINE [USAN]; beta -cytosine arabinoside; beta -D-arabinosylcytosine; Cytosine-beta -arabinoside; CYTARABINE [VANDF]; Epitope ID:768768; CYTARABINE [MART.]; SCHEMBL3140; 1beta -D-Arabinosylcytosine; CYTARABINE [USP-RS]; CYTARABINE [WHO-DD]; CYTARABINE [WHO-IP]; BIDD:PXR0139; Lopac0_000316; MLS000758310; MLS001066340; MLS001424023; 1-beta-D-Arabinosyl-Cytosine; BIDD:GT0371; CYTARABINE [EMA EPAR]; cytosine-b-D-arabinofuranoside; Cytosine, beta -D-arabinoside; 1beta -Arabinofuranasylcytosine; Cytarabine (JP18/USP/INN); Cytarabine - Bio-X trade mark; GTPL4827; orb1309161; orb3141269; 1-ss-D-Arabinofuranosylcytosine; CYTARABINE [ORANGE BOOK]; SCHEMBL22591193; SCHEMBL23152019; 1beta -D-Arabinofuranosylcytosine; CYTARABINE [EP MONOGRAPH]; CYTARABINE [USP IMPURITY]; 1-(b-D-Arabinofuranosyl)cytosine; Cytosine, 1-beta -D-arabinosyl-; 1-beta -d-arabinofuranosylcytosine; 1-beta-D-arabinofuranosyl cytosine; CYTARABINE [USP MONOGRAPH]; Cytosine-beta -D-arabinofuranoside; GLXC-07791; HMS2051K19; HMS2090A18; HMS2230M16; HMS3713N12; 1-beta -D-Arabinofaranosylcytosine; CYTARABINE LIPOSOME [VANDF]; CYTARABINUM [WHO-IP LATIN]; Tox21_111203; Tox21_301971; BDBM50087289; CCG-51297; EBC-13057; HY-13605R; MSK001344; s1648; AKOS007930145; AKOS015896896; Cytosine, 1-beta -D-arabinofuranosyl-; DB00987; KS-5063; MSK001344-100W; NA05771; NC00070; SDCCGSBI-0050304.P002; Cytarabine Solution in Water, 100ug/mL; NCGC00093356-04; NCGC00093356-05; NCGC00093356-06; NCGC00093356-19; NCGC00093356-30; NCGC00142483-02; NCGC00255381-01; BA164339; HY-13605; SRI-10828-19; SRI-10828-20; SRI-10828_24; SY004943; SL-000002; C2035; C9778; NS00005949; SW197450-5; C02961; D00168; EN300-118320; 1-BETA-D-ARABINOFURANOSYLCYTOSINE; ARA-C; F222319; Q180983; SR-01000721860; SR-01000075773-3; SR-01000075773-5; SR-01000721860-6; 1-beta -D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone; 2(1H)-Pyrimidinone, 4-amino-1- -D-arabinofuranosyl; 4-Amino-1-(b-D-Arabinofuranosyl)-2(1H)pyrimidinone; 4-Amino-1-|_-D-arabinofuranosyl-2(1H)-pyrimidinone; BRD-K33106058-001-07-7; BRD-K33106058-001-16-8; BRD-K33106058-003-20-6; 2(1H)-Pyrimidinone, 4-amino-1beta -D-arabinofuranosyl-; Cytosine -D-arabinofuranoside;Cytosine Arabinoside;Ara-C; Z1511499171; 2(1H)-Pyrimidinone, 4-amino-1-beta -D-arabinofuranosyl-; Cytarabine, European Pharmacopoeia (EP) Reference Standard; Cytarabine, United States Pharmacopeia (USP) Reference Standard; Cytosine beta-D-arabinofuranoside, crystalline, >=90% (HPLC); Cytosine beta-D-arabinofuranoside, Vetec(TM) reagent grade, 90%; Cytarabine, Pharmaceutical Secondary Standard; Certified Reference Material; Cytosine -D-arabinofuranoside hydrochloride;Cytosine Arabinoside hydrochloride;Ara-C hydrochlorideTên gọi khác